Clariant reported sales of 1,062 million Swiss francs for the 4th quarter, down 20% on the same period a year earlier.

At the same time, EBITDA came to 106 million Swiss francs, down 31%, with the margin reduced to 10% from 11.6% a year earlier.

For the full year, Clariant recorded sales of 4,377 million Swiss francs, down 16%, for EBITDA of 607 million Swiss francs (-25%).

For 2024 as a whole, Clariant expects a further easing of the inflationary environment, but no economic recovery, with persistent macroeconomic uncertainties and risks.

Clariant therefore expects low-single-digit sales growth in local currency. Reported EBITDA margin should improve to around 15%, and cost savings from restructuring programs should yield CHF 25 million in 2024, estimates the chemical industry company.


Copyright (c) 2024 CercleFinance.com. All rights reserved.